| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| T Suzuki, M Funada, M Narita, M Misawa, H Nagas. Morphine-induced place preference in the CXBK mouse: characteristics of mu opioid receptor subtypes. Brain research. vol 602. issue 1. 1993-04-12. PMID:8383571. |
the blocking effect of sch23390 on the morphine-conditioned place preference suggests that mu 2 receptors may regulate the dopaminergic system, especially dopamine d1 receptors, and are also involved in the reinforcing effects of morphine. |
1993-04-12 |
2023-08-12 |
mouse |
| M F Suaud-Chagny, P Brun, M Buda, F Gono. Fast in vivo monitoring of electrically evoked dopamine release by differential pulse amperometry with untreated carbon fibre electrodes. Journal of neuroscience methods. vol 45. issue 3. 1993-04-09. PMID:1363483. |
dopamine release was evoked in the nucleus accumbens of rats anaesthetized with urethane by electrical stimulation of the mesolimbic dopaminergic pathway. |
1993-04-09 |
2023-08-11 |
rat |
| A Elverfors, J Jonason, G Jonason, G Leonsson, H Nissbrand. Determination of release of endogenous dopamine from superfused substantia nigra slices. Journal of neuroscience methods. vol 45. issue 3. 1993-04-09. PMID:1363484. |
dopamine (da) is synthesized and released not only from the terminals of the nigrostriatal dopaminergic neuronal pathway but also from cell bodies and dendrites in the substantia nigra (sn). |
1993-04-09 |
2023-08-11 |
Not clear |
| L W Zhou, S P Zhang, T A Connell, B Weis. Cholinergic lesions of mouse striatum induced by AF64A alter D2 dopaminergic behavior and reduce D2 dopamine receptors and D2 dopamine receptor mRNA. Neurochemistry international. vol 22. issue 3. 1993-04-06. PMID:8443571. |
cholinergic lesions of mouse striatum induced by af64a alter d2 dopaminergic behavior and reduce d2 dopamine receptors and d2 dopamine receptor mrna. |
1993-04-06 |
2023-08-12 |
mouse |
| L W Zhou, S P Zhang, T A Connell, B Weis. Cholinergic lesions of mouse striatum induced by AF64A alter D2 dopaminergic behavior and reduce D2 dopamine receptors and D2 dopamine receptor mRNA. Neurochemistry international. vol 22. issue 3. 1993-04-06. PMID:8443571. |
to determine whether dopamine receptors are expressed in acetylcholine-containing neurons intrinsic to the striatum, and to study further the interactions between the dopaminergic and cholinergic systems, the irreversibly acting cholinergic neurotoxin, ethylcholine mustard aziridinium ion (af64a), was injected unilaterally into the mouse corpus striatum, and rotational behavior induced by dopamine agonists and certain molecular events associated with this lesion were determined 7 days after lesioning. |
1993-04-06 |
2023-08-12 |
mouse |
| H Jikihara, H Ikegami, K Koike, K Wada, K Morishige, H Kurachi, K Hirota, A Miyake, O Tanizaw. Intraventricular administration of histidyl-proline-diketopiperazine [Cyclo(His-Pro)] suppresses prolactin secretion and synthesis: a possible role of Cyclo(His-Pro) as dopamine uptake blocker in rat hypothalamus. Endocrinology. vol 132. issue 3. 1993-04-01. PMID:7679984. |
chp did not affect [3h]dopamine release from dispersed tuberoinfundibular dopaminergic neurons at any concentration up to 1 microm. |
1993-04-01 |
2023-08-12 |
rat |
| E Ronken, F L Van Muiswinkel, A H Mulder, A N Schoffelmee. Opioid receptor-mediated inhibition of evoked catecholamine release from cultured neurons of rat ventral mesencephalon and locus coeruleus. European journal of pharmacology. vol 230. issue 3. 1993-04-01. PMID:8095023. |
the effects of selective opioid agonists on the evoked release of [3h]dopamine and [3h]noradrenaline were studied in cultured dopaminergic neurons of the ventral mesencephalon (containing the substantia nigra and ventral tegmental area) and in cultured neurons of the noradrenergic locus coeruleus, respectively. |
1993-04-01 |
2023-08-12 |
human |
| E Ronken, F L Van Muiswinkel, A H Mulder, A N Schoffelmee. Opioid receptor-mediated inhibition of evoked catecholamine release from cultured neurons of rat ventral mesencephalon and locus coeruleus. European journal of pharmacology. vol 230. issue 3. 1993-04-01. PMID:8095023. |
after 9 days in culture, the calcium-dependent release of [3h]dopamine from dopaminergic substantia nigra/ventral tegmental area neurons induced by 23 mm k+ appeared to be inhibited exclusively by activation of kappa-opioid receptors, as [3h]dopamine release was inhibited selectively by the kappa agonists u69,593 and dynorphin-(1-13) (ec50 8 and 5 nm, respectively), and this inhibitory effect was antagonized by the kappa-selective antagonist nor-binaltorphimine (ki 0.07 nm). |
1993-04-01 |
2023-08-12 |
human |
| G Flemström, B Säfsten, G Jedsted. Stimulation of mucosal alkaline secretion in rat duodenum by dopamine and dopaminergic compounds. Gastroenterology. vol 104. issue 3. 1993-04-01. PMID:8095035. |
stimulation of mucosal alkaline secretion in rat duodenum by dopamine and dopaminergic compounds. |
1993-04-01 |
2023-08-12 |
rat |
| G Rudolf, N Wiolan. Acute blockade of dopamine receptors with haloperidol: a retinal model to study impairments of dopaminergic transmission. European journal of pharmacology. vol 230. issue 3. 1993-04-01. PMID:8382615. |
acute blockade of dopamine receptors with haloperidol: a retinal model to study impairments of dopaminergic transmission. |
1993-04-01 |
2023-08-12 |
chicken |
| G Rudolf, N Wiolan. Acute blockade of dopamine receptors with haloperidol: a retinal model to study impairments of dopaminergic transmission. European journal of pharmacology. vol 230. issue 3. 1993-04-01. PMID:8382615. |
acute blockade of retinal dopaminergic transmission with haloperidol, a mixed antagonist, produced a dose-correlated tep voltage decrease which was rapidly reversed by intravitreal injection of dopamine. |
1993-04-01 |
2023-08-12 |
chicken |
| G Rudolf, N Wiolan. Acute blockade of dopamine receptors with haloperidol: a retinal model to study impairments of dopaminergic transmission. European journal of pharmacology. vol 230. issue 3. 1993-04-01. PMID:8382615. |
these data confirm the hypothesis that dopamine released by light from amacrine cells triggers light-induced changes in the tep of the intact chicken eye, and that these potentials could well provide an electrophysiological tool to evaluate retinal dopaminergic deficiency. |
1993-04-01 |
2023-08-12 |
chicken |
| C Waldmann, O Güntürkü. The dopaminergic innervation of the pigeon caudolateral forebrain: immunocytochemical evidence for a 'prefrontal cortex' in birds? Brain research. vol 600. issue 2. 1993-03-23. PMID:8435748. |
the dopaminergic (da) innervation of the caudal telencephalon of the pigeon was investigated with an antiserum against glutaraldehyde-conjugated dopamine. |
1993-03-23 |
2023-08-12 |
pigeon |
| F Filloux, J J Townsen. Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection. Experimental neurology. vol 119. issue 1. 1993-03-15. PMID:8432353. |
prior interruption of the dopaminergic nigrostriatal pathway (by injection of 6-hydroxydopamine) appeared to potentiate the toxicity of intrastriatal dopamine injection. |
1993-03-15 |
2023-08-12 |
rat |
| V L Trudeau, B D Sloley, A O Wong, R E Pete. Interactions of gonadal steroids with brain dopamine and gonadotropin-releasing hormone in the control of gonadotropin-II secretion in the goldfish. General and comparative endocrinology. vol 89. issue 1. 1993-03-11. PMID:8094059. |
since the release of gth-ii in goldfish is under a tonic dopaminergic inhibitory tone, the possibility of sex steroids modulating brain and pituitary dopamine was examined in vivo and in vitro. |
1993-03-11 |
2023-08-12 |
Not clear |
| O Benkert, G Gründer, H Wetze. Dopamine autoreceptor agonists in the treatment of schizophrenia and major depression. Pharmacopsychiatry. vol 25. issue 6. 1993-03-08. PMID:1362997. |
dopamine autoreceptor agonists reduce the firing rate, synthesis, and release of dopamine in dopaminergic neurons by means of a negative feedback mechanism via stimulation of autoreceptors. |
1993-03-08 |
2023-08-11 |
Not clear |
| O Benkert, G Gründer, H Wetze. Dopamine autoreceptor agonists in the treatment of schizophrenia and major depression. Pharmacopsychiatry. vol 25. issue 6. 1993-03-08. PMID:1362997. |
for dopamine autoreceptor agonists, therapeutic effects by readjustment of excessive or deficient dopaminergic function have been postulated for positive and negative schizophrenic symptomatology as well as for subtypes of depressive disorders. |
1993-03-08 |
2023-08-11 |
Not clear |
| O Benkert, G Gründer, H Wetze. Dopamine autoreceptor agonists in the treatment of schizophrenia and major depression. Pharmacopsychiatry. vol 25. issue 6. 1993-03-08. PMID:1362997. |
in order to reduce the excess of central dopaminergic activity postulated by the dopamine hypothesis of schizophrenia, dopamine autoreceptor agonists have been tested in open clinical trials in positive schizophrenic symptomatology. |
1993-03-08 |
2023-08-11 |
Not clear |
| F Marchal, A Bairam, P Haouzi, J M Hascoet, J P Crance, P Vert, S Lahir. Dual responses of carotid chemosensory afferents to dopamine in the newborn kitten. Respiration physiology. vol 90. issue 2. 1993-03-08. PMID:1494718. |
it is concluded that the dopaminergic mechanisms are active in the carotid body of the kitten, and the observed responses to dopamine and haloperidol are qualitatively similar to those reported in the adult cat. |
1993-03-08 |
2023-08-11 |
cat |
| J W Kebabian, D R Britton, M P DeNinno, R Perner, L Smith, P Jenner, R Schoenleber, M William. A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets. European journal of pharmacology. vol 229. issue 2-3. 1993-03-02. PMID:1362704. |
in rats with unilateral 6-ohda (6-hydroxydopamine) lesions of the nigro-striatal dopaminergic pathway, a-77636 elicits prolonged (> 20 h) contralateral turning that is blocked by sch 23390, a d1 receptor antagonist, but not by haloperidol at doses selective for the dopamine d2 receptor. |
1993-03-02 |
2023-08-11 |
mouse |